Although we did not measure ERK1/2 and TRAF, we speculate that, even taking into account the fragile tissue observed in emphysema (Suki et al., 2013), VV22.5 might not trigger this inflammatory pathway. The gene discussed is MAPK3; the disease is pulmonary emphysema.